Integra Lifesciences Holdings Corp IART:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/25/21 EST
69.24quote price arrow down-1.00 (-1.42%)
Volume
462,091
52 week range
34.21 - 71.34

...

Loading . . .

KEY STATS

  • Open69.52
  • Day High71.15
  • Day Low68.75
  • Prev Close69.24
  • 52 Week High71.34
  • 52 Week High Date02/17/21
  • 52 Week Low34.21
  • 52 Week Low Date03/18/20
  • Market Cap5.835B
  • Shares Out84.27M
  • 10 Day Average Volume0.44M
  • Dividend-
  • Dividend Yield-
  • Beta1.24
  • 1 Year % Change22.51

RATIOS/PROFITABILITY

  • EPS (TTM)1.58
  • P/E (TTM)43.96
  • Fwd P/E (NTM)25.20
  • EBITDA (MRQ)335.435M
  • ROE (MRQ)9.13%
  • Revenue (MRQ)1.372B
  • Gross Margin (MRQ)64.55%
  • Net Margin (MRQ)9.76%
  • Debt To Equity (MRQ)102.61%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Integra Lifesciences Holdings Corp News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Integra LifeSciences Holdings Corporation provides regenerative technologies and neurosurgical solutions. The Company offers a portfolio of brands including AmnioExcel, Bactiseal, Certas, Codman, CUSA, DuraGen, DuraSeal, ICP Express, Integra, MediHoney, MicroFrance, PriMatrix, SurgiMend, TCC-EZ, and VersaTru. The Company offers solutions in orthopedics, neurosurgery, and reconstructive and general surgery. The Company operates through two segments: Codman Specialty Surgical...
Stuart Essig Ph.D.
Chairman
Peter Arduini
Chief Executive Officer
Glenn Coleman
Chief Operating Officer
Carrie Anderson
Chief Financial Officer
Robert Davis Jr.
Executive Vice President
Address
1100 CAMPUS ROAD
Princeton, NJ
08540
United States